Tenaya Therapeutics
TNYA
101 hedge funds and large institutions have $39.7M invested in Tenaya Therapeutics in 2026 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 17 reducing their positions, and 19 closing their positions.
940% more call options, than puts
Call options by funds: $499K | Put options by funds: $48K
88% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 17
6% more capital invested
Capital invested by funds: $37.5M → $39.7M (+$2.23M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.25% less ownership
Funds ownership: 25.03% → 24.77% (-0.25%)
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
2% less funds holding
Funds holding: 103 → 101 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.21M |
| 2 |
Millennium Management
New York
|
+$739K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$606K |
| 4 |
Renaissance Technologies
New York
|
+$431K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$278K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kalehua Capital Management
Dallas,
Texas
|
-$1.38M |
| 2 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$1.05M |
| 3 |
Two Sigma Investments
New York
|
-$683K |
| 4 |
AI
Alphabet Inc
Mountain View,
California
|
-$632K |
| 5 |
Jane Street
New York
|
-$554K |
TNYA Hedge Fund Activity: Q2 2026 in Review
101 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q2 2026, worth a combined $39.7M — up 5.9% from $37.5M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of TNYA and 18 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 32 added.
The largest buyer was GSA Capital Partners, adding an estimated $1.21M. The largest seller was Kalehua Capital Management, exiting entirely with an estimated $1.38M sold.
- 101 institutional investors held Tenaya Therapeutics (TNYA) as of Q2 2026, down from 103 in Q1 2026.
- Funds reported $39.7M of Tenaya Therapeutics stock for Q2 2026, up 5.9% quarter-over-quarter.
- 18 funds opened new Tenaya Therapeutics positions in Q2 2026 and 19 closed out, a net change of -1 holder.
- The largest Tenaya Therapeutics buyer in Q2 2026 was GSA Capital Partners, an estimated $1.21M added.
- The largest Tenaya Therapeutics seller in Q2 2026 was Kalehua Capital Management, an estimated $1.38M sold.
Based on aggregated 13F filings for Q2 2026.